| 5 mins | 30 mins | Hourly | Daily | Weekly |
|---|---|---|---|---|
| SELL | NEUTRAL | BUY | BUY | BUY |
| 5 mins | 30 mins | Hourly | Daily | Weekly | |
|---|---|---|---|---|---|
| MA5 | 2.97▼ | 2.98▼ | 2.98▼ | 2.96▼ | 2.92▲ |
| MA10 | 2.97▼ | 2.98▼ | 2.95▲ | 2.99▼ | 2.49▲ |
| MA20 | 2.98▼ | 2.94▲ | 2.90▲ | 2.94▲ | 2.27▲ |
| MA50 | 2.98▼ | 2.94▲ | 2.99▼ | 2.42▲ | 2.61▲ |
| MA100 | 2.95▲ | 3.00▼ | 2.99▼ | 2.27▲ | 2.36▲ |
| MA200 | 2.90▲ | 2.98▼ | 2.74▲ | 2.50▲ | 4.22▼ |
| 5 mins | 30 mins | Hourly | Daily | Weekly | |
|---|---|---|---|---|---|
| MACD | -0.003▼ | 0.006▲ | 0.017▲ | -0.041▼ | 0.147▲ |
| RSI | 38.720▼ | 53.417▲ | 51.910▲ | 57.408▲ | 62.043▲ |
| STOCH | 13.333▼ | 70.574 | 84.237▲ | 41.986 | 82.623▲ |
| WILL %R | -100.000▼ | -35.484 | -20.370▲ | -56.250 | -20.359▲ |
| CCI | -146.269▼ | 3.450 | 60.859 | -38.986 | 99.037 |
| ▲ GAP | $NRXP Open Gap Up %2 | Set Alert |
|
Thursday, May 14, 2026 02:48 AM
Detailed price information for Nrx Pharmaceuticals Inc (NRXP-Q) from The Globe and Mail including charting and trades.
|
|
Wednesday, May 13, 2026 05:36 AM
Detailed price information for Nrx Pharmaceuticals Inc (NRXP-Q) from The Globe and Mail including charting and trades.
|
|
Wednesday, May 06, 2026 07:20 PM
Receives FDA Clearance For Depression And Suicidality Trial. NRx Pharmaceuticals (NASDAQ: NRXP) announced that the U.S. Food and Drug Administration cleared the company to initiate a Phase 2/3 clinica ...
|
| date | open | high | low | close | volume |
|---|---|---|---|---|---|
| 13/05/26 | 2.93 | 3.02 | 2.89 | 2.95 | 757,903 |
| 12/05/26 | 2.82 | 2.92 | 2.74 | 2.87 | 721,937 |
| 11/05/26 | 3.07 | 3.07 | 2.80 | 2.82 | 1,349,036 |
| 08/05/26 | 3.08 | 3.125 | 3.01 | 3.08 | 984,405 |
| 07/05/26 | 3.04 | 3.07 | 2.935 | 3.06 | 852,453 |
| 06/05/26 | 3.04 | 3.10 | 2.92 | 3.05 | 1,082,463 |
| 05/05/26 | 3.06 | 3.21 | 3.0282 | 3.04 | 1,333,387 |
| 04/05/26 | 3.16 | 3.201 | 2.99 | 3.00 | 1,173,095 |
| 01/05/26 | 2.95 | 3.10 | 2.9101 | 3.09 | 484,197 |
| 30/04/26 | 2.92 | 3.07 | 2.88 | 2.98 | 959,069 |
|
|
||||
|
|
||||
|
|